Controlled release microencapsulated ngf formulation

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 38/18 (2006.01) A61K 9/50 (2006.01) A61P 25/02 (2006.01)

Patent

CA 2293575

NGF microencapsulation compositions having controlled release characteristics, preferably with increased stability, for the NGF component, particularly human recombinant NGF ("rhNGF") are provided that yield enhanced stability of NGF for use in promoting nerve cell growth, repair, survival, differentiation, maturation or function. Methods for making and using such compositions are also provided.

Cette invention se rapporte à des compositions de microencapsulation du facteur de croissance du tissu nerveux (NGF), ayant des caractéristiques de libération régulée, de préférence avec une stabilité accrue, pour le composant NGF, en particulier le NGF recombiné humain (rhNGF), ces compositions permettant de produire une stabilité accrue du NGF pour qu'il puisse servir à stimuler la croissance, la réparation, la survie, la différenciation, la maturation ou la fonction des cellules nerveuses. Des procédés de fabrication et d'utilisation de ces compositions sont également présentées.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Controlled release microencapsulated ngf formulation does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Controlled release microencapsulated ngf formulation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Controlled release microencapsulated ngf formulation will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1765050

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.